These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
9273 related items for PubMed ID: 1622150
21. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases. Porgador A, Tzehoval E, Vadai E, Feldman M, Eisenbach L. Cancer Res; 1995 Nov 01; 55(21):4941-9. PubMed ID: 7585534 [Abstract] [Full Text] [Related]
22. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue. Donskov F, Basse PH, Hokland M. Nat Immun; 1995 Nov 01; 15(2-3):134-46. PubMed ID: 9162263 [Abstract] [Full Text] [Related]
23. Cytotoxicity against autologous, allogeneic, and xenogeneic tumor targets by human recombinant interleukin-2-activated lymphocytes from healthy dogs and dogs with lung tumors. Mitchell DH, Withrow SJ, Johnston MR, Kruse CA. Am J Vet Res; 1991 Jul 01; 52(7):1132-6. PubMed ID: 1892269 [Abstract] [Full Text] [Related]
24. Lymphokine-activated killer cell susceptibility and multidrug resistance in small cell lung carcinoma. Savas B, Kerr PE, Ustun H, Cole SP, Pross HF. Anticancer Res; 1998 Jul 01; 18(6A):4355-61. PubMed ID: 9891492 [Abstract] [Full Text] [Related]
25. Adoptive immunotherapy of a rat glioma using lymphokine-activated killer cells and interleukin 2. Tzeng JJ, Barth RF, Clendenon NR, Gordon WA. Cancer Res; 1990 Jul 15; 50(14):4338-43. PubMed ID: 2364388 [Abstract] [Full Text] [Related]
26. Efficacy of different immunotherapy approaches toward treatment of doxorubicin-resistant and doxorubicin-sensitive transplantable rhabdomyosarcoma. Belova OB, Vinnichuk UD, Shlakhovenko VA, Berezhnaya NM. Exp Oncol; 2007 Dec 15; 29(4):272-6. PubMed ID: 18199982 [Abstract] [Full Text] [Related]
27. Immunotherapy of murine hepatic metastases with lymphokine-activated killer cells expanded in serum-free media and recombinant interleukin 2. Lafreniere R, Borkenhagen K, Bryant LD, Huchcroft S. Cancer Res; 1989 May 01; 49(9):2409-14. PubMed ID: 2565160 [Abstract] [Full Text] [Related]
28. Monoclonal antibody therapy of murine lymphoma: enhanced efficacy by concurrent administration of interleukin 2 or lymphokine-activated killer cells. Schultz KR, Klarnet JP, Peace DJ, Cheever MA, Badger CC, Bernstein ID, Greenberg PD. Cancer Res; 1990 Sep 01; 50(17):5421-5. PubMed ID: 2386946 [Abstract] [Full Text] [Related]
29. Interleukin 2 protects hairy leukemic cells from lymphokine-activated killer cell-mediated cytotoxicity. Reiter Z, Taylor MW. Cancer Res; 1993 Aug 01; 53(15):3555-60. PubMed ID: 7687924 [Abstract] [Full Text] [Related]
30. Tumor blood supply and tumor localization by adoptively transferred IL-2 activated natural killer cells. Nannmark U, Hokland ME, Agger R, Christiansen M, Kjaergaard J, Goldfarb RH, Bagge U, Unger M, Johansson BR, Albertsson PA, Basse PH. In Vivo; 2000 Aug 01; 14(5):651-8. PubMed ID: 11125549 [Abstract] [Full Text] [Related]